Next Innovative Clinical Research - Chicago /ID# 273453 — Chicago, Illinois

Next Innovative Clinical Research - Chicago /ID# 273453 is a clinical research site located in Chicago, Illinois, United States 60616.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Next Innovative Clinical Research - Chicago /ID# 273453 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Next Innovative Clinical Research - Chicago /ID# 273453?

Next Innovative Clinical Research - Chicago /ID# 273453 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Next Innovative Clinical Research - Chicago /ID# 273453 conducted?

Next Innovative Clinical Research - Chicago /ID# 273453 has 1 clinical trials on record, with 1 currently active. Their work covers Rheumatoid Arthritis.

Is Next Innovative Clinical Research - Chicago /ID# 273453 accredited by Crixeo Health?

Next Innovative Clinical Research - Chicago /ID# 273453 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Next Innovative Clinical Research - Chicago /ID# 273453?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.